Yohimbine anxiogenesis in the elevated plus maze requires hindbrain noradrenergic neurons that target the anterior ventrolateral bed nucleus of the stria terminalis

European Journal of Neuroscience

Volumn 37, Issue 8, 2013, Pages 1340-1349

  Zheng, Huiyuan ^a   Rinaman, Linda ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Locus coeruleus; Norepinephrine; Nucleus of the solitary tract; Rat; Ventrolateral medulla

Indexed keywords

YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR VENTOLATERAL BED NUCLEUS OF THE STRIA TERMINALIS; ANXIETY; ARTICLE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; LOCUS CERULEUS; MALE; MAZE TEST; MEDULLA OBLONGATA; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; RAT; RHOMBENCEPHALON; SOLITARY TRACT NUCLEUS; STRIA TERMINALIS; VENTROLATERAL MEDULLA;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ADRENERGIC NEURONS; ANIMALS; ANXIETY; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOHISTOCHEMISTRY; MALE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RHOMBENCEPHALON; YOHIMBINE;

EID: 84876309831     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12123     Document Type: Article

References (68)

1. Albrechet-Souza, L. & Brandao, M.L. (2010) Hormonal and cognitive factors associated with the exploratory behavior of rats submitted to repeated sessions of the elevated plus-maze. Psychol. Neurosci., 3, 43-52.
2. Albrechet-Souza, L., Borelli, K.G. & Brandao, M.L. (2008) Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus maze. J. Neurosci. Methods, 169, 109-118.
3. Aston-Jones, G., Delfs, J.M., Druhan, J. & Zhu, Y. (1999) The bed nucleus of the stria terminalis: a target site for noradrenergic actions in opiate withdrawal. Ann. NY Acad. Sci., 877, 486-498.
4. 2 challenge? J. Psychopharmacol., 17, 252-259.
5. Baldwin, H.A., Johnston, A.L. & File, S.E. (1989) Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur. J. Pharmacol., 159, 211-215.
6. Banihashemi, L. & Rinaman, L. (2006) Noradrenergic inputs to the bed nucleus of the stria terminalis and paraventricular nucleus of the hypothalamus underlie hypothalamic-pituitary-adrenal axis but not hypophagic or conditioned avoidance responses to systemic yohimbine. J. Neurosci., 26, 11442-11453.
7. Barlow, D.H. (2002) Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. The Guilford Press, New York.
8. Bertoglio, L.J. & Carobrez, A.P. (2000) Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav. Brain Res., 108, 197-203.
9. Bertoglio, L.J. & Carobrez, A.P. (2004) Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behav. Pharmacol., 15, 45-54.
10. Bienkowski, M.S. & Rinaman, L. (2008) Noradrenergic inputs to the paraventricular hypothalamus contribute to hypothalamic-pituitary-adrenal axis and central Fos activation in rats after acute systemic endotoxin exposure. Neuroscience, 156, 1093-1102.
11. Bienkowski, M.S. & Rinaman, L. (2013) Common and distinct neural inputs to the medial central nucleus of the amygdala and the anterior ventrolateral bed nucleus of stria terminalis in rats. Brain Struct. Funct., 218, 187-208.
12. Braun, A.A., Skelton, M.R., Vorhees, C.V. & Williams, M.T. (2011) Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents. Pharmacol. Biochem. Behav., 97, 406-415.
13. Bremner, J.D., Krystal, J.H., Southwick, S.M. & Charney, D.S. (1996a) Noradrenergic mechanisms in stress and anxiety: I. Preclinical Studies. Synapse, 23, 28-38.
14. Bremner, J.D., Krystal, J.H., Southwick, S.M. & Charney, D.S. (1996b) Noradrenergic mechanisms in stress and anxiety: II. Clinical Studies. Synapse, 23, 39-51.
15. Cai, L., Bakalli, H. & Rinaman, L. (2012) Yohimbine anxiogenesis in the elevated plus maze is disrupted by bilaterally disconnecting the bed nucleus of the stria terminalis from the central nucleus of the amygdala. Neuroscience, 223, 200-208.
16. Carobrez, A.P. & Bertoglio, L.J. (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci. Biobehav. Rev., 29, 1193-1205.
17. Cecchi, M., Khoshbouei, H., Javors, M. & Morilak, D.A. (2002a) Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience, 112, 13-21.
18. Cecchi, M., Khoshbouei, H. & Morilak, D.A. (2002b) Modulatory effects of norepinephrine, acting on alpha1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology, 43, 1139-1147.
19. Cecchi, M., Capriles, N., Watson, S.J. & Akil, H. (2007) β1 adrenergic receptors in the bed nucleus of stria terminalis mediate differential responses to opiate withdrawal. Neuropsychopharmacol., 32, 589-599.
20. Charney, D.S. & Deutch, A. (1996) A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit. Rev. Neurobiol., 10, 419-446.
21. Charney, D.S., Heninger, G.R. & Redmond, D.E. Jr. (1983) Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Science, 33, 19-29.
22. Charney, D.S., Bremner, J.D. & Redmond, D.E. Jr. (1995) Noradrenergic neural substrates for anxiety and fear: Clinical associations based on preclinical research. In Bloom, F.E. & Kupfer, D.J. (Eds), Psychopharmacology: The Fourth Generation of Progress. Raven Press, NY, pp. 387-395.
23. Chrousos, G.P. & Gold, P.W. (1992) The concept of stress and stress system disorders: overview of physical and behavioral homeostasis. J. Am. Med. Assoc., 267, 1244-1252.
24. Crespi, F. (2009) Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety. J. Neurosci. Methods, 180, 97-105.
25. Dayas, C.V., Buller, K.M., Crane, J.W., Xu, Y. & Day, T.A. (2001) Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur. J. Neurosci., 14, 1143-1152.
26. Delfs, J.M., Zhu, Y., Druhan, J.P. & Aston-Jones, G. (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature, 403, 430-434.
27. Fendt, M., Siegl, S. & Steiniger-Brach, B. (2005) Noradrenaline transmission within the ventral bed nucleus of the stria terminalis is critical for fear behavior induced by trimethylthiazoline, a component of fox odor. J. Neurosci., 25, 5998-6004.
28. Fernandes, C. & File, S.E. (1996) The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol. Biochem. Behav., 54, 31-40.
29. File, S.E., Mabbutt, P.S. & Hitchcott, P.K. (1990) Characterisation of the phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology, 102, 98-101.
30. File, S.E., Zangrossi, H. Jr., Viana, M. & Graeff, F.G. (1993) Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology, 111, 491-494.
31. Fraley, G.S. & Ritter, S. (2003) Immunolesion of norepinephrine and epinephrine afferents to medial hypothalamus alters basal and 2-deoxy-d-glucose-induced neuropeptide Y and agouti gene-related protein messenger ribonucleic acid expression in the arcuate nucleus. Endocrinology, 144, 75-83.
32. Galvis-Alonsoa, O.Y., Garciac, A.M.B., Orejarenaa, M.J., Lampreae, M.R., Botelhof, S., Conded, C.A., Moratoc, S. & Garcia-Cairascoa, N. (2010) A combined study of behavior and Fos expression in limbic structures after re-testing Wistar rats in the elevated plus-maze. Brain Res. Bull., 81, 595-599.
33. Goes, T.C., Antunes, F.D. & Teixeira-Silva, F. (2009) Trait and state anxiety in animal models: is there correlation? Neurosci. Lett., 450, 266-269.
34. Gurguis, G.N.M., Vitton, B.J. & Uhde, T.W. (1997) Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Psychiat. Res., 71, 27-39.
35. Hogg, S. (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav., 54, 21-30.
36. Ippoliti, R., Lendaro, E., Bellelli, A. & Brunori, M. (1992) A ribosomal protein is specifically recognized by saporin, a plant toxin which inhibits protein synthesis. FEBS Lett., 298, 145-148.
37. Madden, C.J., Ito, S., Rinaman, L., Wiley, R.G. & Sved, A.F. (1999) Lesions of the C1 catecholaminergic neurons of the ventrolateral medulla in rats using anti-DbH saporin. Am. J. Physiol., 277, R1063-R1075.
38. Madden, C.J., Stocker, S.D. & Sved, A.F. (2006) Attenuation of homeostatic responses to hypotension and glucoprivation after destruction of catecholaminergic rostral ventrolateral medulla neurons. Am. J. Physiol. Regul. Integr. Comp. Physiol., 291, R751-R759.
39. McLean, I.W. & Nakane, P.K. (1974) Periodate-lysine-paraformldehyde fixative. A new fixative for immunoelectron microscopy. J. Histochem. Cytochem., 22, 1077-1083.
40. Morilak, D.A., Cecchi, M. & Khoshbouei, H. (2003) Interactions of norepinephrine and galanin in the central amygdala and lateral bed nucleus of the stria terminalis modulate the behavioral response to acute stress. Life Sci., 73, 715-726.
41. Morilak, D.A., Barrera, G., Echevarria, D.J., Garcia, A.S., Hernandez, A., Ma, S. & Petre, C.O. (2005) Role of brain norepinephrine in the behavioral response to stress. Prog. Neuropsychopharmacol. Biol. Psych., 29, 1214-1224.
42. Myers, E.A. & Rinaman, L. (2002) Viscerosensory activation of noradrenergic inputs to the amygdala in rats. Physiol. Behav., 77, 723-729.
43. Myers, E.A. & Rinaman, L. (2005) Trimethylthiazoline (TMT) supports conditioned flavor avoidance and activates viscerosensory, hypothalamic, and limbic circuits in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 288, R1716-R1726.
44. Myers, E.A., Banihashemi, L. & Rinaman, L. (2005) The anxiogenic drug yohimbine activates central viscerosensory circuits in rats. J. Comp. Neurol., 492, 426-441.
45. Onaka, T. & Yagi, K. (1998) Role of noradrenergic projections to the bed nucleus of the stria terminalis in neuroendocrine and behavioral responses to fear-related stimuli in rats. Brain Res., 788, 287-293.
46. Pacák, K., McCarty, R., Palkovits, M., Kopin, I.J. & Goldstein, D.S. (1995) Effects of immobilization on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats. Brain Res., 688, 242-246.
47. Palkovits, M., Baffi, J.S. & Pacák, K. (1999) The role of ascending neuronal pathways in stress-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats. J. Neuroendocrinol., 11, 529-539.
48. Paxinos, G. & Watson, C. (1997) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
49. Pellow, S., Chopin, P., File, S.E. & Briley, M. (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods, 14, 149-167.
50. Pellow, S., Johnston, A.L. & File, S.E. (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J. Pharm. Pharmacol., 39, 917-928.
51. Rinaman, L. (2003) Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expression in rats after gastric viscerosensory stimulation. J. Neurosci., 23, 10084-10092.
52. Rinaman, L. (2011) Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions. Am. J. Physiol. Regul. Integr. Comp. Physiol., 300, R222-R235.
53. Ritter, S., Watts, A.G., Dinh, T.T., Sanchez-Watts, G. & Pedrow, C. (2003) Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion. Endocrinology, 144, 1357-1367.
54. Schiltz, J.C. & Sawchenko, P.E. (2007) Specificity and generality of the involvement of catecholaminergic afferents in hypothalamic responses to immune insults. J. Comp. Neurol., 502, 455-467.
55. Schweimer, J., Fendt, M. & Schnitzler, H.-U. (2005) Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats. Eur. J. Pharmacol., 507, 117-124.
56. Shin, J.-W., Geerling, J.C. & Loewy, A.D. (2008) Inputs to the ventrolateral bed nucleus of the stria terminalis. J. Comp. Neurol., 511, 628-657.
57. Southwick, S.M., Bremner, J.D., Rasmusson, A., Morgan, C.A. III, Arnsten, A. & Charney, D.S. (1999) Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol. Psychiat., 46, 1192-1204.
58. Sullivan, G.M., Coplan, J.D., Kent, J.M. & Gorman, J.C. (1999) The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol. Psychiat., 46, 1205-1218.
59. Treit, D., Menard, J. & Royan, C. (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav., 44, 463-469.
60. Walf, A.A. & Frye, C.A. (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc., 2, 322-328.
61. Walker, D.L., Toufexis, D.J. & Davis, M. (2003) Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur. J. Pharmacol., 463, 199-216.
62. Walker, D.L., Miles, L.A. & Davis, M. (2009) Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog. Neuropsychopharmacol. Biol. Psych., 33, 1291-1308.
63. Wall, P.M. & Messier, C. (2001) Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neurosci. Biobehav. Rev., 25, 275-286.
64. Watanabe, T., Nakagawa, T., Yamamoto, R., Maeda, A., Minami, M. & Satoh, M. (2003) Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Psychopharmacology, 170, 80-88.
65. Watson, R.E., Wiegand, S.T., Clough, R.W. & Hoffman, G.E. (1986) Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides, 7, 155-159.
66. Woulfe, J.M., Hrycyshyn, A.W. & Flumerfelt, B.A. (1988) Collateral axonal projections from the A1 noradrenergic cell group to the paraventricular nucleus and bed nucleus of the stria terminalis in the rat. Exp. Neurol., 102, 121-124.
67. Wrenn, C.C., Picklo, M.J., Lappi, D.A., Robertson, D. & Wiley, R.G. (1996) Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings. Brain Res., 740, 175-184.
68. Zhu, L. & Onaka, T. (2002) Involvement of medullary A2 noradrenergic neurons in the activation of oxytocin neurons after conditioned fear stimuli. Eur. J. Neurosci., 16, 2186-2198.